Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) (345392)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: May 16, 2023 (Letter of inquiry)

Later deadlines: Jun 16, 2023 (Full proposal), Sep 16, 2023 (Letter of inquiry), Oct 16, 2023 (Full proposal), Jan 16, 2024 (Letter of inquiry), Feb 16, 2024 (Full proposal), May 16, 2024 (Letter of inquiry), Jun 16, 2024 (Full proposal), Sep 16, 2024 (Letter of inquiry), Oct 16, 2024 (Full proposal)

Grant amount: Up to US $275,000

Fields of work: Mental Health & Psychiatric Diseases Women's Health Reproductive Health Endocrinology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


Reissue of RFA-MH-21-106 The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary researchers to collaborate on studies of mood and psychosis during the MT. Aspects of mood and psychosis disorders that are of interest include: classic depressive symptoms in combination with menopause symptoms (e.g., hot flashes, night sweats, sleep disturbance) and psychological challenges, the role of reproductive steroids in the regulation of mood and behavior during the MT, diagnosis of mood and psychosis symptoms at menopausal stage, investigation of co-occurring psychiatric and menopause symptoms, appreciation of psychosocial factors common in midlife, and differential diagnoses. Review criteria will focus on the comprehensiveness of the neurobiology and mechanisms of action underlying mood and psychosis symptoms and hypothesis-driven work.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed January 16, 2023 and last updated January 16, 2023